WEBINAR - Archives
- Category: Webinar Archives
- Created on Thursday, 17 April 2014
There is much to learn about how a diverse, robust gastrointestinal microbiota is essential to the health of our gastrointestinal and immune systems. This presentation will review the critical role the gut microbiota plays in maintaining health. Participants will understand that the human intestinal microbiota functions as an organ and is critical for immune and gastrointestinal system maturation, colonization resistance, modulation of immune responses, and nutritional needs. The use of probiotics and prebiotics to support a healthful gut microbiota will be covered in practical details. Probiotics are microorganisms that when consumed provide numerous health benefits. A variety of probiotics are available to health practitioners; most of them are lactic acid bacteria and bifidobacteria. The disorders in which the beneficial use of probiotics is documented include antibiotic-associated GI distress, C. difficile-associated diarrhea, inflammatory bowel disease, irritable bowel disease, dysbiosis, urinary tract infections, allergies, atopic dermatitis, eczema, and lactose intolerance. Multispecies probiotics are generally more effective than single species formulas. Prebiotics increase the numbers and/or activities of healthful gut microbiota. Prebiotics are useful to increase Bifidobacterium populations and to support populations of healthful genera such as Eubacterium and Rosaburia that are not available as probiotics. Participants will learn clinically relevant prebiotic and probiotic interventions that are beneficial for a number of common gastrointestinal and allergic disorders. This presentation will foster an appreciation of the intestinal microbiota and provide participants with the knowledge needed to effectively use prebiotocs and probiotics to enhance health.
Stephen F. Olmstead, MD, is Chief Science Officer at ProThera, Inc. where he directs clinical trials of ProThera® and Klaire Labs™ nutraceutical products. He received his MD from the University of New Mexico in 1979 and completed his Internal Medicine residency at Harvard Medical School, Massachusetts General Hospital in 1982 and fellowship in Cardiovascular Diseases at the University of Washington in 1987. Dr. Olmstead served 2 years in the Commissioned Corps of the US Public Health Service and was stationed primarily at the Indian Health Service Hospital in Gallup New Mexico. For many years, Dr. Olmstead spent his career as a Clinical Assistant Professor in Medicine at the University of Washington Medical School in Seattle. His current research focuses on the use of enzymes and chelating agents to disrupt pathogenic GI biofilm and pre- and probiotics to restore gut microbial balance.
Click Here for a PDF copy of the slide presentation used in this webinar.